Get the Stockscreener App
3.49
0.00%
0.00
After Hours:
3.57
0.08
+2.29%
Compass Therapeutics Inc stock is traded at $3.49, with a volume of 1.17M.
It is up +0.00% in the last 24 hours and up +15.56% over the past month.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.
See More
Previous Close:
$3.49
Open:
$3.49
24h Volume:
1.17M
Relative Volume:
1.02
Market Cap:
$482.61M
Revenue:
-
Net Income/Loss:
$-45.44M
P/E Ratio:
-9.9714
EPS:
-0.35
Net Cash Flow:
$-42.28M
1W Performance:
-5.16%
1M Performance:
+15.56%
6M Performance:
+61.20%
1Y Performance:
+101.73%
1-Day Range:
$3.41
$3.585
1-Week Range:
$3.28
$3.81
52-Week Range:
$1.27
$4.08
Compass Therapeutics Inc Stock (CMPX) Company Profile
Name
Compass Therapeutics Inc
Sector
Industry
Phone
617-500-8099
Address
80 GUEST STREET, BOSTON
Compare CMPX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CMPX
Compass Therapeutics Inc
|
3.49 | 598.79M | 0 | -45.44M | -42.28M | -0.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
381.87 | 96.56B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
449.58 | 60.08B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
555.51 | 61.15B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
711.09 | 44.66B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
328.71 | 36.23B | 3.81B | -644.79M | -669.77M | -6.24 |
Compass Therapeutics Inc Stock (CMPX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-01-25 | Resumed | Raymond James | Outperform |
| Apr-02-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Feb-24-25 | Initiated | Guggenheim | Buy |
| Feb-19-25 | Initiated | Piper Sandler | Overweight |
| Dec-23-24 | Initiated | D. Boral Capital | Buy |
| Nov-15-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Sep-16-24 | Upgrade | Ladenburg Thalmann | Neutral → Buy |
| Jan-31-23 | Initiated | Jefferies | Buy |
| Jan-27-23 | Initiated | Stifel | Buy |
| May-23-22 | Resumed | H.C. Wainwright | Buy |
| Mar-15-22 | Initiated | Ladenburg Thalmann | Buy |
| Jan-19-22 | Initiated | B. Riley Securities | Buy |
| Dec-22-21 | Initiated | Raymond James | Outperform |
| Dec-20-21 | Initiated | SVB Leerink | Outperform |
| Dec-15-21 | Initiated | Wedbush | Outperform |
View All
Compass Therapeutics Inc Stock (CMPX) Latest News
Forecasting Compass Therapeutics Inc. price range with options dataJuly 2025 EndofMonth & Weekly Setup with High ROI Potential - newser.com
Compass Therapeutics Inc. stock volume spike explainedJuly 2025 Movers & AI Based Buy and Sell Signals - newser.com
Compass Therapeutics, Inc. (NASDAQ:CMPX) Given Consensus Rating of "Buy" by Brokerages - MarketBeat
Why Compass Therapeutics Inc. is moving todayMarket Trend Review & Low Drawdown Trading Techniques - newser.com
How to use a screener to detect Compass Therapeutics Inc. breakouts2025 EndofYear Setup & Safe Entry Zone Tips - newser.com
Can swing trading help recover from Compass Therapeutics Inc. lossesJuly 2025 Sentiment & Risk Controlled Stock Pick Alerts - newser.com
Backtesting results for Compass Therapeutics Inc. trading strategiesJuly 2025 Catalysts & Weekly Chart Analysis and Guides - newser.com
Is Compass Therapeutics, Inc. (CMPX) the Hottest Smid-Cap Stock So Far In 2025? - MSN
Combining machine learning predictions for Compass Therapeutics Inc.2025 Major Catalysts & Pattern Based Trade Signal System - newser.com
Market Wrap: Can Compass Therapeutics Inc sustain its profitability2025 Bull vs Bear & Expert Curated Trade Setups - خودرو بانک
Guidance Update: What makes CYCUW stock attractive todayQuarterly Risk Review & Precise Buy Zone Identification - khodrobank.com
Will breakout in Compass Therapeutics Inc. lead to full recoveryJuly 2025 EndofMonth & Reliable Trade Execution Plans - newser.com
Will Compass Therapeutics Inc. outperform the marketJuly 2025 EndofMonth & Risk Controlled Daily Trade Plans - newser.com
Volatility clustering patterns for Compass Therapeutics Inc.2025 Market Overview & Real-Time Volume Analysis Alerts - newser.com
Compass Therapeutics Inc. stock outlook for YEARPortfolio Gains Summary & Target Return Focused Stock Picks - newser.com
Multi factor analysis applied to Compass Therapeutics Inc.Quarterly Profit Review & Long-Term Growth Stock Strategies - newser.com
Chart based analysis of Compass Therapeutics Inc. trendsShort Setup & Free Technical Pattern Based Buy Signals - newser.com
Sentiment Recap: Will CAPL stock hit new highs in YEARJuly 2025 Update & Fast Momentum Stock Entry Tips - khodrobank.com
Portfolio Shifts: Will Compass Therapeutics Inc. benefit from AI trendsShare Buyback & High Accuracy Buy Signal Tips - خودرو بانک
Historical volatility pattern of Compass Therapeutics Inc. visualizedRecession Risk & Smart Swing Trading Techniques - newser.com
Live market analysis of Compass Therapeutics Inc.Profit Target & Trade Opportunity Analysis - newser.com
Buyout Rumor: What are the future prospects of CHKPPortfolio Risk Report & AI Enhanced Trading Alerts - خودرو بانک
How high can Compass Therapeutics Inc. stock goJuly 2025 Final Week & Weekly Top Performers Watchlists - newser.com
Analyst Upgrade: Can Compass Therapeutics Inc. maintain its current growth rate2025 Price Targets & Low Drawdown Momentum Ideas - khodrobank.com
Gains Recap: Does Compass Therapeutics Inc. have strong fundamentalsJuly 2025 Macro Moves & Real-Time Volume Analysis - خودرو بانک
Revenue Check: Is Compass Therapeutics Inc stock forming a cup and handleJuly 2025 Trade Ideas & AI Based Buy/Sell Signal Reports - خودرو بانک
Insider Sell: Is XPER in a bullish channelWeekly Investment Report & Free Fast Gain Swing Trade Alerts - khodrobank.com
Aug Drivers: How liquid is Ardagh Metal Packaging SA Equity Warrant stockQuarterly Risk Review & Safe Entry Momentum Tips - خودرو بانک
Aug Chart Watch: Is NOVONIX Limited Depositary Receipt exposed to political riskTreasury Yields & Daily Entry Point Trade Alerts - khodrobank.com
Decliners Report: Can Hubbell Incorporated deliver alphaTrade Risk Summary & Verified Momentum Watchlists - khodrobank.com
Value Recap: Will RSSS benefit from government policyGlobal Markets & Accurate Buy Signal Notifications - khodrobank.com
Big Picture: Is Compass Therapeutics Inc. a strong growth stock2025 Valuation Update & Detailed Earnings Play Alerts - خودرو بانک
Should you wait for a breakout in Compass Therapeutics Inc.Market Sentiment Summary & Consistent Growth Equity Picks - newser.com
Compass Therapeutics Inc Stock (CMPX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Compass Therapeutics Inc Stock (CMPX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| GORDON CARL L | Director |
Apr 09 '25 |
Sale |
1.59 |
3,571,428 |
5,678,571 |
0 |
| ORBIMED ADVISORS LLC | Director |
Apr 09 '25 |
Sale |
1.59 |
3,571,428 |
5,678,571 |
0 |
2.43%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):